Guardian Pharmacy Services (GRDN) Q2 FY26 earnings call

Guardian Pharmacy Services delivered a solid second quarter, demonstrating strong underlying business growth and effective mitigation of IRA pricing impacts on profitability. The company raised its full-year guidance for both revenue and adjusted EBITDA, driven by operational efficiencies and strategic expansions. Leadership transitions were completed to support future growth, while capital deployment remains focused on M&A and greenfield opportunities, with an eye on potential Omnicare assets.